Navigation Links
Increasing Affluence and Legislative Reforms are Transforming Poland's Pharmaceutical Market, Which Holds Strategic Importance for Multinational Companies
Date:10/23/2013

BURLINGTON, Mass., Oct. 23, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Poland's increasing affluence, as well as its myriad reforms and policy initiatives on healthcare quality, access, privatization and financing, have contributed to growth in the country's pharmaceutical market during much of the last decade. Poland has experienced several years of significant growth in public drug reimbursement expenditure. With a $4.7 billion prescription drug market in 2012, this large and populous central European country holds strategic importance for multinational companies looking beyond the major pharmaceutical markets for growth opportunities.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

However, according to the Poland Market Access Tracker, the market entry of multinationals in Poland is hampered by a number of challenges including the country's traditionally low prices for reimbursed drugs, its relatively high patient copayment levels, a large market share for generic drugs and its relatively low spend on healthcare as a percentage of gross domestic product. Additionally, the 2012 Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Purposes and Medical Devices Act (commonly known as the "Reimbursement Act") has caused radical changes in drug assessment, pricing and reimbursement, and has—in a very short time frame—become one of the most restrictive reimbursement regulations in all Europe. After several years of healthy growth in the prescription drugs sector in Poland, the Reimbursement Act drove a sharp 13.4 percent decline in prescription drug sales in 2012.

"Poland's initiatives on improving the transparency of drug pricing and reimbursement and on the use of health technology assessment to foster cost-effective use of drugs can ultimately benefit innovators who show the clinical and economic benefits of their therapies to the Polish health system," said Decision Resources Analyst Laurie DiModica, M.S. "Drug manufacturers operating in Poland now have the opportunity to enter into risk-sharing agreements with the government based on clinical outcomes and expected cost savings. This has enabled drug makers to avoid the potential for a hefty payback required of manufacturers when the government's drug reimbursement spending exceeds 17 percent of the annual public healthcare budget. Further, the next few years will be critical to the industry, as the Polish government has signaled its intention to reallocate savings generated through the Reimbursement Act into increasing access to innovative, cost-effective medicines."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increasing Incidence of Cardiovascular Diseases to Drive The Cardiovascular Devices Market in Emerging Countries
2. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
3. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
4. Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities
5. Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend
6. Increasing Minimal Invasive Surgeries to Boost Adoption of Hybrid Operating Rooms in Europe, Says Frost & Sullivan
7. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
8. Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth
9. RMANJ Research Demonstrates That Egg Freezing Prior To IVF Yields Positive Outcomes Without Increasing Risk Of Aneuploidy
10. Global Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth: MarketResearchReports.Biz
11. AssureRx Health Expands Management Team to Support Increasing Business Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... 2017  May is Stroke Awareness Month and Omron ... important methods to prevent a stroke: monitor and manage ... Control and Prevention, undetected and uncontrolled hypertension is a ... global leader in personal heart health technology, recently evolved ... attack and stroke and is advancing a national public ...
(Date:5/4/2017)... and SAN DIEGO , May ... Gynecologists (ACOG) 2017 Annual Clinical and Scientific Meeting— OBP ... illuminating medical devices, today announced the launch of a ... OfficeSPEC and ER-SPEC vaginal specula. ... of extra-small and extra-large sizes makes OBP Medical,s line ...
(Date:5/3/2017)...  Kalorama Information notes that transplant diagnostics is ... and this is projected to continue to 2021. ... or bone marrow transplants require histocompatibility between the ... this task. This according to a new report ... various PCR-based methodologies, Sanger sequencing and NGS used ...
Breaking Medicine Technology:
(Date:5/24/2017)... , ... May 24, 2017 , ... Myers Jackson is ... has the ability to sell luxury homes anywhere on the planet. The luxury home ... side from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction ...
(Date:5/24/2017)... ... May 24, 2017 , ... Accordant Technology, a ... portfolio. ExtraHop delivers an analytics-first approach, layered with machine learning, that provides real-time ... datacenter to the cloud to the edge. Through the new partnership, customers get ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... City (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 ... Home (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... in North Carolina have remained steady since 2009, according to a Workers Compensation ... , The study Monitoring the North Carolina System: CompScope™ Benchmarks, 17th Edition ...
Breaking Medicine News(10 mins):